Company / Capital Expenditures
Organogenesis Holdings Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$24.4M
FY2025
5-year range
$6.0M / $33.9M
FY2021-FY2025
Trend
-28.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 8 years, ranging from $1M in FY2018 to $34M in FY2024.
Based on SEC 10-K filings.
$24M in FY2025 with a 5-year CAGR of +67.3%.
Declined from $31M to $24M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +11.3%
- 5-Year CAGR
- +67.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +67.3%, indicating consistent growth.
- In FY2025, capital expenditures decreased 28.1% year-over-year.
- Peak capital expenditures was recorded in FY2024.
- Lowest capital expenditures in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.4M | -28.1% |
| FY2024 | $33.9M | +8.6% |
| FY2023 | $31.2M | +76.6% |
| FY2022 | $17.7M | +195.4% |
| FY2021 | $6.0M | +222.2% |
| FY2020 | $1.9M | -23.5% |
| FY2019 | $2.4M | +78.3% |
| FY2018 | $1.4M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026